8 matches for your search in the start-up spotlight
rss
Tumour-on-chip model supports preclinical drug development on pancreatic cancer
10-Mar-2025
The biotech company Dynamic42, a specialist in organ-on-chip technology, has made a significant advance in pancreatic cancer drug research in collaboration with the research team of Prof. Dr. Nicole Teusch at the Institute of Pharmaceutical Biology and Biotechnology at Heinrich Heine University ...
Dynamic42 and research partners present three-organ system to reduce animal testing
20-Feb-2025
Organ-on-chip specialist Dynamic42 and ESQlabs, experts in digital life sciences solutions, have successfully developed a three-organ system, in close collaboration with Consumer Health Division of Bayer, and the Placenta Lab at Jena University Hospital. The platform has the potential to ...
Successful cooperation between science, clinic and start-up
25-Mar-2024
The Jena-based biotech company Dynamic42 has developed an intestine-on-chip candidiasis model that allows for the quantification of the infection process. By combining microbiological and image-based analyses, the pathogen-host interactions can be analyzed much more precisely than is possible ...
New partnership to promote pioneering in vitro systems in drug development
30-Jan-2024
The organ-on-chip specialist Dynamic42 GmbH and Biopredic, manufacturer of assay systems for research, announce a strategic Marketing agreement. The joint partnership aims to advance the development of in vitro assay systems by using human-relevant models in the early phase of drug ...
Flexible and customized Organ-on-Chip Solutions for Advanced Drug Testing
15-Jun-2023
Innovative organ-on-chip specialist Dynamic42 GmbH has closed a mid-seven-figure financing round. The company, which was spun off from the “Center of Sepsis Control and Care” of the University Hospital Jena in March 2018, was able to convince both the previous lead investor bm-t ...
“The chip allows us to dive into completely new application areas for organ-on-chip technology”
19-Apr-2023
Dynamic42 GmbH started the production of a new generation of innovative biotech chips for the organ-on-chip technology. With this chip, developed in-house, the effect of chemical substances can be examined directly on human organ replicas. In addition, complex models relating to immunological ...
Cooperation between Bayer, the start-ups esqLABS and Dynamic42, and Placenta Lab of Jena University Hospital
08-Mar-2023
A first-of-its-kind collaboration in the consumer health industry is developing a platform aimed at reducing or replacing animal testing using “organ-on-chip” (OoC) technology and interactive computational software. The pilot project, supported by esqLABS, Dynamic42, Placenta Lab of Jena ...
Interdisciplinary knowledge exchange
15-Feb-2023
With an academy at the BioInstrumentezentrum in Jena, the biotech company Dynamic42 GmbH is supplementing its services in the field of advanced training. The company began in 2018 with the development of models on biotech chips, which are used to test drugs and other substances on human organ ...
